ACET Adicet Bio Inc
Price (delayed)
$0.7655
Market cap
$63.3M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.33
Enterprise value
$21.13M
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta
Highlights
ACET's EPS has surged by 60% year-on-year and by 22% since the previous quarter
Adicet Bio's debt has decreased by 18% YoY and by 5% QoQ
Adicet Bio's equity has decreased by 12% QoQ but it has increased by 10% YoY
The quick ratio has increased by 12% YoY but it has decreased by 11% from the previous quarter
Key stats
What are the main financial stats of ACET
Market
Valuations
Earnings
Shares outstanding
82.69M
Market cap
$63.3M
Enterprise value
$21.13M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.34
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$127.62M
Net income
-$117.12M
EBIT
-$117.12M
EBITDA
-$107.45M
Free cash flow
-$93.5M
Per share
Balance sheet
Liquidity
EPS
-$1.33
EPS diluted
-$1.33
Free cash flow per share
-$1.06
Book value per share
$2.26
Revenue per share
$0
TBVPS
$2.51
Total assets
$220.22M
Total liabilities
$33.61M
Debt
$17.23M
Equity
$186.61M
Working capital
$160.74M
Debt to equity
0.09
Current ratio
9.29
Quick ratio
9.24
Net debt/EBITDA
0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-45.6%
Return on equity
-52.5%
Return on invested capital
-119.5%
Return on capital employed
-58.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACET stock price
How has the Adicet Bio stock price performed over time
Intraday
-3.58%
1 week
-9.52%
1 month
-14.9%
1 year
-65.98%
YTD
-20.43%
QTD
-20.43%
Financial performance
How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$127.62M
Net income
-$117.12M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 18% YoY
ACET's operating income is up by 16% YoY
Growth
What is Adicet Bio's growth rate over time
Valuation
What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.34
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS has surged by 60% year-on-year and by 22% since the previous quarter
ACET's price to book (P/B) is 68% lower than its 5-year quarterly average of 1.1 and 30% lower than its last 4 quarters average of 0.5
Adicet Bio's equity has decreased by 12% QoQ but it has increased by 10% YoY
Efficiency
How efficient is Adicet Bio business performance
Adicet Bio's ROIC has soared by 55% YoY and by 28% from the previous quarter
ACET's ROE is up by 20% YoY and by 2.6% QoQ
Adicet Bio's return on assets has increased by 18% YoY
Dividends
What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACET.
Financial health
How did Adicet Bio financials performed over time
ACET's current ratio is down by 13% since the previous quarter but it is up by 10% year-on-year
The quick ratio has increased by 12% YoY but it has decreased by 11% from the previous quarter
Adicet Bio's debt is 91% lower than its equity
ACET's debt to equity is down by 25% YoY
Adicet Bio's debt has decreased by 18% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.